Immunoprofile of adenocarcinomas of the endometrium, endocervix, and ovary with mucinous differentiation Journal Article


Authors: Park, K. J.; Bramlage, M. P.; Ellenson, L. H.; Pirog, E. C.
Article Title: Immunoprofile of adenocarcinomas of the endometrium, endocervix, and ovary with mucinous differentiation
Abstract: Primary mucinous tumors of the female genital tract have morphologic features similar to primary gastrointestinal adenocarcinomas, and distinguishing these malignancies may be extremely difficult. The purpose of this study was to characterize the immunostaining patterns of tumors of the female genital tract that show mucinous differentiation using cytokeratin 7 (CK7), CK20, and CDX2 and to evaluate the usefulness of these markers in differentiating these tumors from gastrointestinal tract adenocarcinomas and also from each other. A total of 64 cases were collected, including adenocarcinomas of the ovary (n=13), endocervix (n=16), endometrium (n=34), and vagina (n=1), all of which showed predominant mucinous differentiation. Intestinal mucinous differentiation was present in 11 of the cases (6 endocervical, 4 ovarian, and 1 vaginal adenocarcinoma). All tumors were at least focally positive for CK7 with the exception of 3 cases. The majority of tumors were negative for CK20 and CDX2. However, 25% of endocervical, 24% of ovarian, and 3% of endometrial adenocarcinomas were positive for CDX2, CK20, or both. The positivity for CDX2 and CK20 correlated with intestinal differentiation: 73% of all intestinal mucinous adenocarcinomas and 4% of all Müllerian mucinous adenocarcinomas showed positivity for the hindgut markers. In 70% of the tumors positive for CK20/CDX2, the intensity of CK7 stain was stronger than the intensity of either CK20 or CDX2 stain. In conclusion, immunostaining for CK7/CK20/CDX2 is helpful in distinguishing Müllerian subtype of mucinous gynecologic tumors from lower gastrointestinal tract malignancies. In gynecologic mucinous tumors with intestinal differentiation, the overlap of staining positivity may be a limiting factor. However, a dominant CK7 staining pattern was observed. © 2009 Lippincott Williams & Wilkins, Inc.
Keywords: immunohistochemistry; controlled study; human tissue; unclassified drug; major clinical study; endometrium carcinoma; adenocarcinoma; ovary adenocarcinoma; ovarian neoplasms; differential diagnosis; tumor differentiation; neoplasm proteins; tumor markers, biological; homeodomain proteins; pathology; tumor marker; evaluation; ovary tumor; tumor protein; immunophenotyping; cytokeratin 20; keratin-20; cytokeratin 7; homeodomain protein; uterine cervical neoplasms; cdx2 protein, human; keratin-7; uterine cervix tumor; tissue differentiation; uterine cervix; uterine cervix carcinoma; endometrium; mucinous carcinoma; cervix uteri; cdx2; ck20; ck7; female genital tract; gi adenocarcinomas; müllerian; mucinous; transcription factor cdx2; intestine carcinoma; muellerian duct; vagina carcinoma
Journal Title: Applied Immunohistochemistry & Molecular Morphology
Volume: 17
Issue: 1
ISSN: 1541-2016
Publisher: Lippincott Williams & Wilkins  
Date Published: 2009-01-01
Start Page: 8
End Page: 11
Language: English
DOI: 10.1097/PAI.0b013e318174f012
PUBMED: 18776815
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 2" - "Export Date: 30 November 2010" - "CODEN: AIMMF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kay Jung Park
    308 Park